Pediatric outlook for anti-IgE therapy;Perspectives pédiatriques des anti-IgE

Revue Francaise d'Allergologie et d'Immunologie Clinique

Volumn 45, Issue 7, 2005, Pages 550-554

  Aboutaam, R ^a   Scheinmann, P ^a   De Blic, J ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Allergic rhinitis; Anti IgE therapy; Asthma; Children; Omalizumab

Indexed keywords

IMMUNOGLOBULIN E ANTIBODY; OMALIZUMAB; PLACEBO;

ADD ON THERAPY; ALLERGIC ASTHMA; ALLERGIC RHINITIS; BRAZIL; CANADA; CLINICAL TRIAL; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; HUMAN; IMMUNOTHERAPY; LICENCE; MARKETING; MEDICAL ASSESSMENT; NEW ZEALAND; RESPIRATORY TRACT ALLERGY; REVIEW; TREATMENT OUTCOME; UNITED STATES;

EID: 27144510141     PISSN: 03357457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.allerg.2005.07.006     Document Type: Article

References (15)

1. R. Djukanovic Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma Am. J. Respir. Crit. Care Med. 170 2004 583 593
2. H. Milgrom Treatment of allergic asthma with monoclonal anti-IgE antibody rhuMAb-E25 Study Group N. Engl. J. Med. 341 1999 1966 1973
3. S. Walker Anti-IgE for chronic asthma in adults and children Cochrane Database Syst. Rev. 3 2004 (CD003559)
4. www.ccohta.ca.
5. S. Holgate Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy Clin. Exp. Allergy 35 2005 408 162005
6. J. Bousquet The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma Allergy 60 2005 302 308
7. M. Humbert Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE Allergy 60 2005 309 316
8. H. Milgrom Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab) Pediatrics 108 2001 E36
9. R. Lemanske Omalizumab improves asthma-related quality of life in children with allergic asthma Pediatrics 110 2002 e55
10. W. Berger Evaluation of long-term safety of the anti-IgE antibody, omalizumab, in children with allergic asthma Ann. Allergy Asthma Immunol. 91 2003 182 188
11. A. Vignola Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR Allergy 59 2004 709 717
12. C. Rolinck-Werninghaus The co-seasonal application of anti-IgE after preseasonal specific immunotherapy decreases ocular and nasal symptom scores and rescue medication use in grass pollen allergic children Allergy 59 2004 973 979
13. J. Kuehr Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis J. Allergy Clin. Immunol. 109 2 2002 274 280
14. D. Leung Effect of anti-IgE therapy in patients with peanut allergy N. Engl. J. Med. 348 2003 986 993
15. www.ginasthma.com.